1. First episode of bloody diarrhoea- is it IBD?
2. A case of mild to moderate Crohn’s disease

Reporting IBD in clinical practice: The Proper Way

Key Note Address:
1. Changing Lifestyles and Epidemiology in the search for the etiology of IBD
2. IBD : From Etiopathogenesis to Clinical Practice

State of art lectures :
1. Fibrosis in CD: can we halt the progression?
2. Simply speaking: How do drugs work?
3. Microbiome pills: How far are we?

1. Where pathologists changed the diagnosis: Case-based Discussions
2. The basics of CT and MR interpretation for day to day clinical practice
3. Point of care intestinal ultrasound in IBD: a new skill for the gastroenterologist

1. Small bowel endoscopy: Capsule, Balloon, Spiral - Choosing the right option?
2. From intelligence to artificial intelligence in IBD

AIG LIVE: Endoscopy in IBD
1. Diagnostic & Therapeutic endoscopy in IBD: Novel imaging, Chromoendoscopy, Endocytoscopy, Endobrain
2. Enteroscopy: The spiral way
3. Interventional endoscopy: Strictures, balloons, stents, setons
4. EMR, ESD, TEM, Fecal Transplantation

Expert Opinion:
1. Are all terminal ileal ulcers Crohns?
2. Pre and Probiotics- do they have a future?
3. 5-ASA for Crohn's disease- Yes or No?

A career in IBD: a new sub speciality on the rise : The Western perspective & The Indian Perspective

1. Oral and topical mesalazines: which? when? how long?
2. Budesonide, MMX or Prednisolone in current treatment algorithms
3. Optimizing Azathioprine treatment: What dose? How long?

Admission Orders: What Should They Be?
Days 1-3: Monitoring, Anticipating, Planning
Salvage Therapy: Beyond IV Steroids
The Gastroenterologist's Best Friend: The Surgeon

1. Diet-microbiome interactions: The perfect meal plan in IBD
2. Microbiome based dietary therapy: the Indo-Israeli experience.

1. Ischemia and Microscopic Colitis
2. SUDD/SCAD
3. Checkpoint Inhibitor Colitis

1. 20 years of IBD Research: How near are we to cure?
2. AIG IBD Manual Book release.

1. Anti-TNFs and anti-integrins: Journey so far
2. JAK inhibition: tofacitinib and beyond
3. Ustekinumab: will it be the game changer?
4. Positioning biologics and small molecules: the current perspective
5. Audience Interaction
6. Launch of IBD-ENC Biologics Registry

A 22 year old medical student with perianal fistula: A panel discussion on key Issues : 1. Timing of seton placement
2. Choice of antibiotic
3. Selecting the right biologic

1. Crohn's Disease - post surgery - what next?
2. Recurrent Pouchitis - what next?

1. Exit strategy from maintenance therapy in IBD : When, why & if to stop 5ASA, AZA, biologics?
2. Persistent symptoms in IBD: beyond active disease!
3. Audience interaction

Key Note Address:
Liver disorders in Inflammatory bowel Disease: NASH & Beyond.
Vascular complications of IBD: An overlooked problem.

1. Ileocaecal Disease : Resect or Medicate?
2. Dysplasia in IBD- endoscopic resection or colectomy?

1. Approach to unexplained fever in IBD
2. TDM-Proactive vs Reactive
3. Can Tofa be the first line drug after steroids?
4. Navigating the taboo of Mental and Sexual health in IBD.

1. Common mistakes in management of IBD
2. IBD motherhood: Management of the pregnant and newborn

1. Quiet colon but angry joints
2. Intractable proctitis
3. Case of UC with CMV: Culprit or innocent bystander?

1. IBD in children - how is it different?
2. Approach to a case of early onset IBD
3. Drug dosing in the young IBD